🔗 Permalink

Inventor profile of:

Dhanapalan Nagarathnam

City:

Bethany, Connecticut

Country:

United States

Published Applications:

49

Last publication date:

2024-05-02

Top Assignees for applications by Dhanapalan Nagarathnam

The entities that hold a legal rights for patent applications filed by inventor Nagarathnam Dhanapalan:

GILEAD PHARMASSET LLC 14 Foster City, CA United States
Bayer Pharmaceuticals Corporation 9 West Haven, CT United States
Pharmasset, Inc. 7 Princeton, NJ United States
BAYER HEALTHCARE LLC 6 Tarrytown, NY United States
Rhizen Pharmaceuticals SA 4 La Chaux de Fonds, Switzerland
Gilead Sciences, Inc. 2 Foster City, CA United States
GILEAD PHARMASSET LLC 2 Princeton, NJ United States
Rhizen Pharmaceuticals SA 2 Basel, Switzerland
Gilead Pharmassel LLC 1 Foster City, CA United States

Recent patent applications by Nagarathnam Dhanapalan

Dhanapalan Nagarathnam from Bethany, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-02

US20240139227A1

Human necessities

Nucleoside phosphoramidate prodrugs

#2 | 2021-12-30

US20210403475A1

Chemistry; metallurgy

NOVEL SELECTIVE PI3K DELTA INHIBITORS

#3 | 2021-12-30

US20210401840A1

Human necessities

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

#4 | 2021-12-02

US20210371416A1

Chemistry; metallurgy

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES

#5 | 2021-07-01

US20210196741A1

Human necessities

Nucleoside phosphoramidate prodrugs

#6 | 2020-08-27

US20200270258A1

Chemistry; metallurgy

Selective PI3K delta inhibitors

#7 | 2019-09-19

US20190282581A1

Human necessities

Intermediates useful in the synthesis of compounds as modulators of protein kinases

#8 | 2019-06-27

US20190194206A1

Chemistry; metallurgy

Selective PI3K delta inhibitors

#9 | 2019-04-11

US20190105324A9

Human necessities

Substituted chromenones as modulators of protein kinases

#10 | 2018-04-26

US20180110783A1

Human necessities

Substituted chromenones as modulators of protein kinases

#11 | 2018-01-04

US20180000855A1

Human necessities

Nucleoside phosphoramidate prodrugs

#12 | 2015-11-12

US20150320752A1

Human necessities

Compounds as modulators of protein kinases

#13 | 2015-08-20

US20150231166A1

Human necessities

Nucleoside phosphoramidate prodrugs

#14 | 2014-10-23

US20140315852A1

Chemistry; metallurgy

Nucleoside phosphoramidate prodrugs

#15 | 2014-09-25

US20140288020A1

Chemistry; metallurgy

Nucleoside phosphoramidate prodrugs

#16 | 2014-07-03

US20140187511A1

Human necessities

Nucleoside phosphoramidate prodrugs

#17 | 2014-02-13

US20140045783A1

Chemistry; metallurgy

Nucleoside phosphoramidate prodrugs

#18 | 2013-08-29

US20130225519A1

Chemistry; metallurgy

Nucleoside phosphoramidates

#19 | 2013-01-31

US20130029929A1

Human necessities

Nucleoside phosphoramidate prodrugs

#20 | 2012-12-13

US20120316327A1

Chemistry; metallurgy

Synthesis of purine nucleosides

#21 | 2012-10-11

US20120258928A1

Chemistry; metallurgy

Nucleoside cyclicphosphates

#22 | 2012-03-01

US20120053179A1

Chemistry; metallurgy

Rho-Kinase Inhibitors

#23 | 2011-10-27

US20110263597A1

Chemistry; metallurgy

SUBSTITUTED PYRIDINES AND PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY

#24 | 2011-10-20

US20110257122A1

Human necessities

Nucleoside phosphoramidate prodrugs

#25 | 2011-10-20

US20110257121A1

Human necessities

Purine nucleoside phosphoramidate

#26 | 2011-07-12

US10720702

Substituted pyridines and pyridazines with angiogenesis inhibiting activity

#27 | 2011-04-28

US20110098301A1

Chemistry; metallurgy

Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders

#28 | 2011-01-20

US20110015146A1

Chemistry; metallurgy

Nucleoside phosphoramidates

#29 | 2010-11-11

US20100286083A1

Chemistry; metallurgy

Nucleoside analogs

#30 | 2010-11-04

US20100279973A1

Chemistry; metallurgy

Synthesis of purine nucleosides

#31 | 2010-09-30

US20100249159A1

Chemistry; metallurgy

RHO-KINASE INHIBITORS

#32 | 2010-08-26

US20100216789A1

Chemistry; metallurgy

RHO-KINASE INHIBITORS

#33 | 2010-04-01

US20100081628A1

Chemistry; metallurgy

Nucleoside cyclicphosphates

#34 | 2010-03-25

US20100075967A1

Chemistry; metallurgy

PYRIMIDINE DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISORDERS

#35 | 2010-03-11

US20100063107A1

Chemistry; metallurgy

Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer

#36 | 2010-01-21

US20100016251A1

Human necessities

Nucleoside phosphoramidate prodrugs

#37 | 2009-11-19

US20090286785A1

Chemistry; metallurgy

Pyrimidine Derivatives

#38 | 2009-10-15

US20090258888A1

Chemistry; metallurgy

Pyrimidine Derivatives

#39 | 2007-10-11

US20070238741A1

Chemistry; metallurgy

Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors

#40 | 2007-09-13

US20070213339A1

Chemistry; metallurgy

Quinolone Carboxylic Acid Derivatives for Treatment of Hyperproliferative Conditions

#41 | 2007-05-24

US20070117817A1

Chemistry; metallurgy

Pyrimidine derivatives for treatment of hyperproliferative disorders

#42 | 2006-06-29

US20060142314A1

Chemistry; metallurgy

Rho-kinase inhibitors

#43 | 2006-06-29

US20060142295A1

Human necessities

Method of treating cancer with quinolone carboxylic acid derivatives

#44 | 2005-12-15

US20050277640A1

Chemistry; metallurgy

Pyrimidine derivatives for treatment of hyperproliferative disorders

#45 | 2005-09-22

US20050209261A1

Chemistry; metallurgy

Rho-kinase inhibitors

#46 | 2005-09-13

US10349176

Rho-kinase inhibitors

#47 | 2005-09-01

US20050192304A1

Chemistry; metallurgy

Rho-kinase inhibitors

#48 | 2005-08-02

US10349177

Rho-kinase inhibitors

#49 | 2005-06-07

US9636519

Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

InventorID:

68233 ⎘